Benitec Biopharma Inc. (BNTC)

Nasdaq Pharmaceutical Pharmaceutical Preparations SIC: 2834
D
Pipeline Grade

Financial Position (from SEC Filings)

$184.9M
Cash & Equivalents
$11.6M
Quarterly Burn Rate
48 mo
Est. Cash Runway
$461M
Market Cap

Estimated from most recent SEC quarterly filing. View SEC filings

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

No upcoming catalysts detected for this company.

Active Clinical Trials (1)

NCT #TitlePhaseStatusEnrollment
NCT06185673 A Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Ocul... PHASE2 Recruiting 30

Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.

More Analysis

AI Stock Score

SEC EDGAR fundamental analysis with Claude AI & ChatGPT ratings for BNTC.

SEC EDGAR Filings

All SEC filings for Benitec Biopharma Inc. on EDGAR.

Full Calendar

View all upcoming FDA catalysts across all biotech companies.